CAMP4 Therapeutics Corporation share price logo

CAMP4 Therapeutics Corporation

NASDAQ: CAMP

Small Cap

$4.99

-0.45

(-8.27%)

as on

CAMP4 Therapeutics Corporation Stock Performance

as on August 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.78
    $6.00
    downward going graph

    4.21%

    Downside

    20.24%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.41
    $7.75
    downward going graph

    71.74%

    Downside

    55.31%

    Upside

    downward going graph

CAMP4 Therapeutics Corporation share price movements today

Previous Close
$5.44
Open
$5.93
Volume
1.1M
Market Cap
$341.4M
Day's Low - High
$4.78 - $6.00
52 Week Low - High
$1.41 - $7.75

CAMP4 Therapeutics Corporation Historical Returns

1 Month Return
+ 46.63 %
3 Month Return
+ 26.22 %
1 Year Return
+ 225.75 %
3 Year Return
-66.92 %
5 Year Return
-97.92 %

CAMP4 Therapeutics Corporation Stock Fundamentals & Key Indicators

Check CAMP4 Therapeutics Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$341.4M

EPS (TTM)

-2.27

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.02

Industry PE ratio

-7.283372093023256

PEG Ratio

-0.12947846619346104

EBITDA

-52.2M

Revenue (TTM)

3.9M

Profit Margin

61.59%

Return On Equity TTM

-314.08%

CAMP4 Therapeutics Corporation Stock Valuation

Track how CAMP4 Therapeutics Corporation P/E has moved over time to understand its valuation trends.

CAMP4 Therapeutics Corporation in the last 5 years

  • Overview

  • Trends

Lowest (-12.13x)

February 28, 2022

Industry (-7.28x)

December 31, 2025

Today (-2.31x)

December 31, 2025

Highest (-1.97x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -2.31x

CAMP4 Therapeutics Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of CAMP4 Therapeutics Corporation with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
SELL$341.4M-97.92%-2.0261.59%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for CAMP4 Therapeutics Corporation Stock including INR - Dollar returns

The CAMP4 Therapeutics Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

CAMP4 Therapeutics Corporation investment value today

Current value as on today

₹3,27,142

Returns

₹2,27,142

(+227.14%)

Returns from CAMP4 Therapeutics Corporation Stock

₹1,98,802 (+198.8%)

Dollar Impact

₹28,340 (+28.34%)

Analyst Recommendation on CAMP4 Therapeutics Corporation Stock

Based on 5 analysts

SELL

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'SELL' rating for CAMP4 Therapeutics Corporation. Average target price of $9.08

CAMP4 Therapeutics Corporation Share Price Target

Get share price movements and forecasts by analysts on CAMP4 Therapeutics Corporation.

What analysts predicted

45.04%UPSIDE

Target Price

$9.08

Current Price

$4.99

Analyzed by

5 Analysts

Target

$9.08

CAMP4 Therapeutics Corporation target price $9.08, a slight upside of 45.04% compared to current price of $4.99. According to 5 analysts rating.

Indian Investors' Interest in CAMP4 Therapeutics Corporation Stock

Search interest for CAMP4 Therapeutics Corporation Stock has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-42% versus previous 30 day period

CAMP4 Therapeutics Corporation Quarterly Profit & Loss

All numbers in Millions USD

Nov 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
0
0
1
0
0
1
Gross Profit
0
0
0
0
0
0
1
0
0
0
Operating Income
-13
-12
-12
-13
-14
-13
-13
-13
-12
-13
EBITDA
-13
-12
-12
-13
-13
-12
-12
-14
-12
-12
Interest Expense
1
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-12
-12
-12
-13
-13
-12
-12
-15
-40
-18
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-12
-12
-12
-13
-13
-12
-12
-15
-40
-18
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
100.00%
100.00%
100.00%
47.67%
100.00%
59.81%

CAMP4 Therapeutics Corporation Annual Profit & Loss

All numbers in Millions USD

Feb 2018
Feb 2019
Feb 2020
Feb 2021
Feb 2022
Feb 2023
Nov 2023
Dec 2024
Dec 2025
Total Revenue
365
363
366
308
295
-
0
0
3
Gross Profit
150
147
143
122
121
0
0
0
1
Operating Income
7
19
-16
-3
-15
-45
-51
-53
-52
EBITDA
31
47
15
18
7
-44
-50
-51
-50
Interest Expense
10
16
20
15
15
6
-
-
-
Depreciation
22
20
31
22
22
0
1
1
1
Income Before Tax
28
23
-58
-20
-30
-44
-49
-51
-80
Income Tax Expense
10
-1
20
0
1
-
-
-
-
Net Income
16
18
-78
-21
-31
-44
-49
-51
-80
Net Profit Margin
41.24%
40.62%
39.14%
39.67%
41.20%
0.00%
100.00%
100.00%
53.14%

CAMP4 Therapeutics Corporation Quarterly Cash Flow

All numbers in Millions USD

Nov 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-12
-12
-12
-13
-13
-12
-12
-15
-40
-18
Operating Cash Flow
-11
-11
-13
-9
-11
-14
-10
-11
6
-10
Investing Cash Flow
0
0
0
0
0
0
-
0
-
-
Financing Cash Flow
0
0
0
0
73
0
0
47
28
0
Change in Cash
-12
-11
-14
-10
61
-14
-10
36
34
-10

CAMP4 Therapeutics Corporation Annual Cash Flow

All numbers in Millions USD

Feb 2018
Feb 2019
Feb 2020
Feb 2021
Feb 2022
Feb 2023
Nov 2023
Dec 2024
Dec 2025
Net Income
16
18
-79
-56
-27
-44
-49
-51
-80
Operating Cash Flow
66
47
11
28
-4
-38
-44
-45
-29
Investing Cash Flow
-26
-21
-65
-13
-7
-4
0
0
0
Financing Cash Flow
-2
98
-94
-27
-2
100
0
71
75
Change in Cash
38
123
-149
-12
-15
83
-44
25
46

Mutual Funds that own CAMP4 Therapeutics Corporation Stock

Check out the Mutual Funds with significant holdings in CAMP4 Therapeutics Corporation.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.38656%
1497643
Fidelity Select Portfolios
2.113371%
1326208
Fidelity Mt. Vernon Street Trust
0.956821%
600436
Fidelity Concord Street Trust
0.455197%
285651
Victory Portfolios III
0.364845%
228952

Global Institutional Holdings in CAMP4 Therapeutics Corporation

Funds
Holdings
Vanguard
2.74%
John Toomey, Jr.
2.03%
iShares
1.42%
Goldman Sachs
0.08%
Xtrackers
0.05%

Insights on CAMP4 Therapeutics Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CAMP stock has moved up by 28.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 595.5% return, outperforming this stock by 662.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 460.9% return, outperforming this stock by 235.2%

About CAMP4 Therapeutics Corporation

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
OrganisationCAMP4 Therapeutics Corporation
HeadquartersOne Kendall Square, Cambridge, MA, United States, 02139
IndustryBiotechnology
CEOMr. Joshua Mandel-Brehm
E-voting on sharesClick here to vote

Key Management of CAMP4 Therapeutics Corporation

Name

Title

Dr. Daniel Tardiff Ph.D.

Chief Scientific Officer

Ms. Michelle Gates

Senior VP & Chief People Officer

Dr. Satya Kuchimanchi Ph.D.

Senior Vice President of Technical Operations

Mr. Joshua Mandel-Brehm

CEO, President & Director

Dr. Richard A. Young Ph.D.

Founder & Independent Director

Ms. Kelly Gold

Chief Financial Officer

Ms. Alla Sigova Ph.D.

Senior Vice President of Platform

Dr. Yuri Maricich M.B.A., M.D.

Chief Medical Officer

Dr. Leonard I. Zon M.D.

Founder & Chairman of Scientific Advisory Board

Mr. Caleb Moore

Chief Business Operations Officer

FAQs

What is CAMP4 Therapeutics Corporation share price today?

CAMP4 Therapeutics Corporation share price today is $4.99 as on at the close of the market. CAMP4 Therapeutics Corporation share today touched a day high of $6.00 and a low of $4.78.

What is the 52 week high and 52 week low for CAMP4 Therapeutics Corporation share?

CAMP4 Therapeutics Corporation share touched a 52 week high of $7.75 on and a 52 week low of $1.41 on . CAMP4 Therapeutics Corporation stock price today i.e. is closed at $4.99,which is 35.61% down from its 52 week high and 253.90% up from its 52 week low.

What is CAMP4 Therapeutics Corporation's market capitalisation today?

CAMP4 Therapeutics Corporation market capitalisation is $0.00T as on .

How to invest in CAMP4 Therapeutics Corporation Stock (CAMP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for CAMP4 Therapeutics Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in CAMP4 Therapeutics Corporation Shares that will get you 0.3006 shares as per CAMP4 Therapeutics Corporation share price of $4.99 per share as on August 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy CAMP4 Therapeutics Corporation Stock (CAMP) from India?

Indian investors can start investing in CAMP4 Therapeutics Corporation (CAMP) shares with as little as ₹95.592 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.92 in CAMP4 Therapeutics Corporation stock (as per the Rupee-Dollar exchange rate as on ). Based on CAMP4 Therapeutics Corporation share’s latest price of $4.99 as on August 18, 2026 at 1:29 am IST, you will get 2.0040 shares of CAMP4 Therapeutics Corporation. Learn more about fractional shares .

What are the returns that CAMP4 Therapeutics Corporation has given to Indian investors in the last 5 years?

CAMP4 Therapeutics Corporation stock has given -97.92% share price returns and 28.34% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?